Screener
Harmony Biosciences Holdings, Inc. HRMY Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| TOTAL ASSETS | $1,271,824 | $1,271,631 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Trade payables | $28,600 | $17,693 |
| Accrued compensation | 6,726 | 18,443 |
| Accrued expenses | 150,107 | 191,039 |
| Current portion of long-term debt | 20,000 | 20,000 |
| Other current liabilities | 11,907 | 4,957 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s accounts payable?
- Harmony Biosciences Holdings, Inc. (HRMY) reported accounts payable of $28.6M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s accounts payable changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s accounts payable increased by 63.8% year-over-year, from $17.46M to $28.6M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s accounts payable has grown at a 47.2% compound annual growth rate (CAGR), from $2.56M to $17.69M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Harmony Biosciences Holdings, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude